Flexible glass developed for tiny medical devices

The researchers at Brigham Young University have developed new glass technology that could add a new level of flexibility to the microscopic world of medical devices.

The researchers at Brigham Young University have developed new glass technology that could add a new level of flexibility to the microscopic world of medical devices.

Led by electrical engineering professor Aaron Hawkins, the researchers have found a way to make the normally brittle material of glass bend and flex. The research opens up the ability to create a new family of lab-on-a-chip devices based on flexing glass.

“If you keep the movements to the nanoscale, glass can still snap back into shape,” Hawkins said. “We’ve created glass membranes that can move up and down and bend. They are the first building blocks of a whole new plumbing system that could move very small volumes of liquid around.”

While current lab-on-a-chip membrane devices effectively function on the microscale, Hawkins’ research, recently published in Applied Physics Letters, will allow equally effective work at the nanoscale. Chemists and biologists could use the nanoscale devices to move, trap and analyze very small biological particles like proteins, viruses and DNA.

So why work with glass? According to lead study author and BYU Ph.D. student John Stout, glass has some great perks: it’s stiff and solid and not a material upon which things react, it’s easy to clean, and it isn’t toxic.

“Glass is clean for sensitive types of samples, like blood samples,” Stout said. “Working with this glass device will allow us to look at particles of any size and at any given range. It will also allow us to analyze the particles in the sample without modifying them.”

The researchers believe their device could also mean performing successful tests using much smaller quantities of a substance. Instead of needing several ounces to run a blood test, the glass membrane device created by Hawkins, Stout and coauthor Taylor Welker would only require a drop or two of blood.

Hawkins said the device should also allow for faster analysis of blood samples: “Instead of shipping a vial of blood to a lab and have it run through all those machines and steps, we are creating devices that can give you an answer on the spot.”

There is an increased demand for portable on-site rapid testing in the healthcare industry. Much of this is being realized through these microfluidic systems and devices, and the BYU device could take that testing to the next level of detail.

“This has the promise of being a rapid delivery of disease diagnosis, cholesterol level testing and virus testing,” Hawkins said. “In addition, it would help in the process of healthcare knowing the correct treatment method for the patient.”

In pic: A graduate student at BYU holds up a disc of microchips that have flexible glass membranes. (Jaren Wilkey/BYU Photo)

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Cattle as Hosts for Human and Bird Flu Viruses: A Potential Public Health ConcernMay 17, 2024
The Ethics of Live Surgery Broadcasts: NMC Seeks Public OpinionMay 17, 2024
Successful Removal of 3.7 KG Large Abdominal Tumor from 14-Year-Old Somalian Girl at KIMS Cuddles HospitalMay 16, 2024
iLEAD Sets a Precedent by Launching a Graphic Anthology Authored by Multimedia, Animation and Graphics Students May 16, 2024
Ramaiah Memorial Hospital Launches Novel Intra-Operative Radiation Therapy (IORT); Achieves significant advancement in Cancer Treatment to Enhance Quality of LifeMay 16, 2024
IIITH Announces Product Management Summer SchoolMay 16, 2024
Çelebi India's Delhi Cargo Terminal Successfully Handles Airbus H125 Helicopter ShipmentMay 16, 2024
Plant-Based Diets and Prostate Cancer: New UCSF Study Shows Promising ResultsMay 16, 2024
National Medical Commission Approves 112 New Medical CollegesMay 16, 2024
Study Suggests That Chemotherapy Results in Physical Decline for Older Women with Breast CancerMay 16, 2024
Google DeepMind's AlphaFold 3: Revolutionizing Drug Discovery with AIMay 16, 2024
Hester Biosciences Ltd reports Consolidated Revenue growth of 18% at Rs. 79.3 crore, EBITDA up 37% to Rs. 16.4 crore and Net Profit up 12% to Rs. 6.40 crore in Q4FY24May 16, 2024
Akshay Tritiya Parna Mahotsav heldMay 16, 2024
IT Minister Sridhar Babu to grace the 10th National Facilities Managers Summit-2024, to be held in the cityMay 15, 2024
Alarming Study Reveals Cancer-Causing Chemicals in Car InteriorsMay 15, 2024
India's Thalassemia Challenge: The Importance of Early Screening and TreatmentMay 15, 2024
The Dangers of Ultra-Processed Foods: A 30-Year Study Raises AlarmsMay 15, 2024
Unique Genetic Risk Factors for Breast Cancer Found in African Ancestry StudyMay 15, 2024
AsiaMedic partners with Sunway to establish new diagnostic imaging centreMay 14, 2024
Kamineni Doctors Successfully Remove Bone Stuck Near Heart in Elderly PatientMay 14, 2024